Delivery Order SPE2DB20D1004-SPE2DB24FF4T0
Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,065.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 220 MCG 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The U.S. Defense Logistics Agency (DLA) awarded a $19,013.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,860,781 units of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. This delivery order contract is part of a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 110 mcg 12gm pharmaceutical products. The contract has a potential value of $2,124.52 and a period of performance through February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,739 units of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract, valued at $2,096.01, has an ultimate completion date of April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,176,783 units of Fluticasone Propionate HFA 220 MCG 12GM. The contract has a ceiling value of $2,318.50 and a performance period through April 8, 2024. This award is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM pharmaceuticals. The $6,296.40 award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of medications...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM medication. The order, valued at $4,462.34, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. The company also holds an indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $1,763.85 and a period of performance through March 21, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of up to...